Ultrasound Probes Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Ultrasound Probes Market size was valued at USD 3.7 billion in 2023 and is estimated to grow at 3.7% CAGR from 2024 to 2032. Ultrasound probes, also known as transducers, are handheld devices used in medical imaging to generate and receive ultrasound waves. These probes consist of piezoelectric crystals that convert electrical energy into mechanical vibrations (sound waves) and vice versa.
Chronic diseases, such as cardiovascular diseases, diabetes, cancer, and respiratory disorders, are becoming more prevalent globally due to factors such as aging populations, sedentary lifestyles, poor dietary habits, and environmental factors. Ultrasound imaging plays a crucial role in diagnosing and monitoring these conditions. According to the World Health Organization (WHO), noncommunicable diseases (NCDs) account for a staggering 74% of global fatalities, with 17 million occurring prematurely before age 70, predominantly in low- and middle-income countries.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Ultrasound Probes Market size in 2023: | USD 3.7 Billion |
Forecast Period: | 2024 to 2032 |
Forecast Period 2023 - 2032 CAGR: | 3.7 |
2023 Value Projection: | USD 5.1 Billion |
Historical Data for: | 2021 - 2023 |
No of Pages: | 196 |
Tables, Charts & Figures: | 285 |
Segments Covered: | Product, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
Among these, cardiovascular diseases are the primary cause, claiming 17.9 million lives yearly, followed by cancer (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million, including diabetes-related kidney disease deaths). Thus, as the burden of chronic diseases grows, the demand for ultrasound probes increases correspondingly, driving ultrasound probes market growth.
Technological innovations, such as the development of more compact, high-resolution probes, as well as features such as 3D/4D imaging, contrast-enhanced imaging, and elastography, enhance the diagnostic capabilities and usability of diagnostic ultrasound which is estimated to reach USD 11 billion by the end of 2032 , further driving its adoption.
Traditionally, ultrasound imaging was primarily performed in specialized imaging centers or hospitals. However, advancements in technology have led to the development of portable and handheld ultrasound devices, making it feasible to use them in point-of-care settings such as clinics, physician offices, emergency rooms, and even in remote or resource-limited areas.
Based on product, the market is divided into probe, software & services, and accessories. The probe segment is further bifurcated into linear probe, convex probe, phased array/cardiac probe, transesophageal (TEE) probe, endocavitary probe, cerebrovascular doppler, and other probes. The probe segment is estimated to account for USD 2.8 billion by the end of 2032.
Based on application, the ultrasound probes market is bifurcated into musculoskeletal, oncology, cardiovascular, obstetrics & gynecology, general imaging, and other applications. The general imaging segment accounted for USD 1 billion in 2023.
Based on end-use, the ultrasound probes market is bifurcated into hospitals and clinics, diagnostic centers, ambulatory surgical centers, and other end-users. The hospitals and clinics companies segment accounted for USD 1.6 billion in 2023.
The ultrasound probes market in North America accounted for a significant market share of 40.8% in 2023, and this trajectory is set to continue upwards.
UK is anticipated to witness robust growth in the global ultrasound probes market.
China ultrasound probes market is anticipated to witness lucrative growth between 2024 – 2032.
South Korea ultrasound probes market is expected to grow significantly over the years.
The ultrasound probes sector is competitive in nature, with a mix of major global and smaller to medium-sized companies competing for market share. A pivotal aspect of market strategy involves the continual introduction of innovative products leveraging diverse technologies. Notably, prominent industry players command significant influence in this dynamic landscape, often driving forward advancements through substantial investments in research and development. Additionally, strategic alliances, acquisitions, and mergers are instrumental in fortifying market positions and expanding global footprint amidst evolving regulatory landscapes.
Some of the eminent market participants operating in the ultrasound probes industry include:
Market, By Product
Market, By Application
Market, By End-use
The above information is provided for the following regions and countries:
Canon Inc., Esaote SPA, Fujifilm Holdings Corporation, GE HealthCare Technologies Inc., Hitachi, Ltd., Koninklijke Philips NV, Mindray Bio-Medical Electronics Co., Ltd., Samsung Electronics Co., Ltd., Siemens Healthineers AG, SonoScape Medical Corp and Terason Division Teratech Corporation.
North America accounted for 40.8% of the market share in 2023, fueled by the rising incidence of chronic ailments, such as cancer cardiovascular diseases, and diabetes.
The market size of ultrasound probes reached USD 3.7 billion in 2023 and is set to witness 3.7% CAGR from 2024 to 2032, led by the increasing prevalence of chronic diseases, such as cardiovascular diseases, diabetes, cancer, and respiratory disorders.
The general imaging segment recorded USD 1 billion in 2023, owing to a wide range of medical conditions and diagnostic needs, making it a versatile and indispensable tool for healthcare providers.